Nebulized Colistin in Ventilator-Associated Pneumonia and Tracheobronchitis: Historical Background, Pharmacokinetics and Perspectives

Clinical evidence suggests that nebulized colistimethate sodium (CMS) has benefits for treating lower respiratory tract infections caused by multidrug-resistant Gram-negative bacteria (GNB). Colistin is positively charged, while CMS is negatively charged, and both have a high molecular mass and are...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhu, Yinggang, Monsel, Antoine, Roberts, Jason A., Pontikis, Konstantinos, Mimoz, Olivier, Rello, Jordi, Qu, Jieming, Rouby, Jean-Jacques
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8227626/
https://www.ncbi.nlm.nih.gov/pubmed/34072189
http://dx.doi.org/10.3390/microorganisms9061154

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8227626/
https://www.ncbi.nlm.nih.gov/pubmed/34072189
http://dx.doi.org/10.3390/microorganisms9061154

Ejemplares similares